Introduction
Surgery can be life-changing, but what follows is just as important. Recovery periods vary greatly and can be hindered by inflammation, scar formation, and tissue degeneration. At RegenU, we leverage regenerative therapies to enhance post-surgical outcomes and accelerate return to normal activity.
The Challenges of Surgical Recovery
After orthopaedic procedures like ACL reconstructions, joint replacements, or cartilage transplants, the body initiates a complex healing cascade. Unfortunately, this natural response can be inefficient or excessive, leading to pain, fibrosis, or delayed tissue regeneration.
RegenU’s Regenerative Solutions for Post-Surgical Recovery
Biological Injectables
We utilise PRP and amniotic-derived products to enhance post-surgical healing. These injectables deliver high concentrations of bioactive proteins, modulating inflammation while stimulating new cell growth (Foster et al., 2009).
Personalised Rehabilitation
Functional movement retraining is essential post-operatively. Our team assesses biomechanics, posture, and joint loading patterns, helping patients regain mobility and prevent maladaptive compensations.
Adjunctive Therapies: Hyperbaric Oxygen Therapy (HBOT)
As part of a comprehensive post-surgical recovery plan, Hyperbaric Oxygen Therapy (HBOT) can play a valuable role in enhancing tissue repair and reducing complications. By delivering 100% oxygen at increased atmospheric pressure, HBOT improves oxygen availability in healing tissues—particularly in areas where circulation may be compromised after surgery. This increased oxygenation supports collagen synthesis, reduces oedema, and helps minimise the risk of infection and excessive scar tissue formation. Integrated alongside biologic injectables and rehabilitation, HBOT provides an added layer of support for faster, more efficient surgical recovery.
The Future of Surgical Rehabilitation
Emerging studies support the role of regenerative medicine in reducing the need for opioid analgesics, shortening rehab duration, and improving surgical outcomes overall (Centeno et al., 2015). At RegenU, our approach is proactive—optimising recovery from day one.
Conclusion
Surgery should not mark the end of treatment, but the start of regeneration. By incorporating regenerative medicine into the post-surgical journey, RegenU offers patients the tools to heal faster, smarter, and more completely, restoring quality of life with fewer complications.
Disclaimer: This blog is for informational purposes only and should not be considered medical advice. Please consult with your healthcare provider for any questions or concerns regarding your individual health.
References
- Centeno, C. J., Schultz, J. R., Cheever, M., Freeman, M., Faulkner, S., & Robinson, B. (2015). Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Current Stem Cell Research & Therapy, 10(5), 307–313. https://doi.org/10.2174/1574888X10666150302001759
- Foster, T. E., Puskas, B. L., Mandelbaum, B. R., Gerhardt, M. B., & Rodeo, S. A. (2009). Platelet-rich plasma: from basic science to clinical applications. The American Journal of Sports Medicine, 37(11), 2259–2272. https://doi.org/10.1177/0363546509349921
- Centeno, C. J., Schultz, J. R., Cheever, M., Freeman, M., Faulkner, S., & Robinson, B. (2015). Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Current Stem Cell Research & Therapy, 10(5), 307–313. https://doi.org/10.2174/1574888X10666150302001759
- Foster, T. E., Puskas, B. L., Mandelbaum, B. R., Gerhardt, M. B., & Rodeo, S. A. (2009). Platelet-rich plasma: from basic science to clinical applications. The American Journal of Sports Medicine, 37(11), 2259–2272. https://doi.org/10.1177/0363546509349921
- Slater, G., & Bachmid, Z. (2023). Hyperbaric Oxygen Therapy as an Accelerator in Regenerative Medicine. Journal of Regenerative Biology and Medicine, 5(4), 293–301. https://doi.org/10.37191/Mapsci-2582-385X-5(4)-139